Leal Therapeutics Announces $45 Million Financing to Progress Novel Therapies for Patients with Major Neurodegenerative and Neuropsychiatric Disorders
Press Releases
Leal Therapeutics, Inc.  
October 30, 2024

Leal Therapeutics Announces $45 Million Financing to Progress Novel Therapies for Patients with Major Neurodegenerative and Neuropsychiatric Disorders

Financing supports advancement of lead programs LTX-002 and LTX-001 to first-in-human trials

avatar profile Olean Times Herald

Olean Times Herald


Local & Social